# CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-286-vich-gl60-good-manufacturing-practice-for-active-pharmaceutical-ingredients-used-in-veterinary-medicinal-products/7f7052eb-5fa4-4d38-b174-a5a3f7b63abc

> FDA guidance document: CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products. Issue date: January 25, 2024. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2024-01-25
- Comment Close Date: 2024-03-25
- Last Changed: 2024-01-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-4761">FDA-2023-D-4761</a>

## Related Documents

- [CVM GFI #285 - Manufacture of Batches in Support of Original NADAs, ANADAs, and CNADAs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-285-manufacture-of-batches-in-support-of-original-nadas-anadas-and-cnadas/d6be7c32-4f76-44ec-95c4-9ac9309d861f)
- [CVM GFI #290 (VICH GL61) – Pharmaceutical Development](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-290-vich-gl61-pharmaceutical-development/e8fd92df-cd71-4f54-be38-a00b312eecbb)
- [CVM GFI #288 Chemistry, Manufacturing, and Controls in Support of Recombinant Protein Products for Veterinary Medicinal Use](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-288-chemistry-manufacturing-and-controls-in-support-of-recombinant-protein-products-for-veterinary-medicinal-use/e1abc597-6139-4802-b4fe-8fc042cf7114)